Leen-Jan van Doorn, Ph.D. (Managing Director) is one of the founders of DDL. He received his Ph.D. in molecular virology from the Erasmus University of Rotterdam, the Netherlands. He has specialized in molecular typing of infectious organisms such as hepatitis B and C, human papillomavirus and respiratory viruses. Dr. van Doorn has published more than 180 papers in international scientific journals as well as various book chapters.
Anco Molijn, M.Sc. (Director of Operations) has extensive experience in the fields of molecular biology, virology and molecular pathology. Before joining DDL in 1998, he worked at the department of pathology of the Erasmus University of Rotterdam and St. Judes Childrens hospital (Memphis, USA).
Roy van der Geest, M.Sc. (Director Legal and Finance) holds a master in Business Administration from the Erasmus University of Rotterdam. Roy previously worked for PriceWaterhouseCoopers and Oaklins Netherlands; a boutique investment bank.
Wim Quint, Ph.D. is one of the founders of DDL and is now president of the Advisory Board. He received his Ph.D. in molecular virology from the University of Nijmegen, the Netherlands. He has specialized in molecular diagnostics of infectious diseases and is a key opinion leader on molecular studies of human papillomavirus. Dr. Quint has published more than 400 papers on various topics in international scientific journals.